Endoplasmic Reticulum Protein 29 (ERp29) as a Novel Prognostic Marker and Tumor Suppressor in Osteosarcoma
Conclusions: These findings suggest a tumor suppressive role of ERp29 in osteosarcoma. In addition, ERp29 might potentially be applied as a prognostic indicator in patients with osteosarcoma.
Source: Journal of Bone Oncology - Category: Cancer & Oncology Source Type: research
More News: Bone Cancers | Bone Graft | Cancer | Cancer & Oncology | Genetics | Osteosarcoma | Statistics | Study